Core Insights - Zoetis, Inc. (ZTS) is anticipated to exceed expectations in its third-quarter 2025 earnings report, scheduled for November 4, 2025, with revenue estimates at $2.41 billion and earnings per share (EPS) at $1.62 [1][5] Group 1: Revenue Sources - The company generates most of its revenue from a diverse portfolio of veterinary medicines and vaccines for livestock and companion animals, with additional income from non-pharmaceutical categories such as nutritional products and precision animal health services [2] - Revenue from the U.S. segment is projected to increase, primarily due to rising sales of companion animal products, with estimates at $1.34 billion according to Zacks Consensus and $1.38 billion based on internal models [3] - The International segment is also expected to see revenue growth, driven by higher sales of companion animal products, with estimates of $1.04 billion from Zacks and $1.03 billion from internal models [4] Group 2: Product Performance - Companion animal products, particularly Simparica Trio, Apoquel, and Cytopoint, are expected to significantly contribute to revenue growth in both U.S. and International segments [5][7] - However, sales of monoclonal antibody products for osteoarthritis, Librela and Solensia, are likely to decline in the U.S. due to concerns over side effects [8] - The FDA's recent approval of a new indication for Simparica Trio is expected to further enhance sales by preventing flea tapeworm infections [9] Group 3: Livestock Products - Livestock product sales in both U.S. and International segments are anticipated to decline due to the divestiture of certain product lines, including medicated feed additives and water-soluble products [10] Group 4: Earnings Surprise History - Zoetis has a strong earnings surprise history, having surpassed estimates in the last four quarters with an average surprise of 6.19%, including an 8.64% surprise in the most recent quarter [11][12] Group 5: Earnings Prediction - The company's earnings model indicates a likely earnings beat, supported by a positive Earnings ESP of +0.32% and a Zacks Rank of 3 [13]

Core Insights - Newell Brands Inc. (NWL) is projected to experience a year-over-year revenue decline of 2.8%, with expected quarterly revenues of $1.89 billion for Q3 2025 [1][10] - The consensus estimate for earnings per share (EPS) is 18 cents, reflecting a growth of 12.5% compared to the previous year [2][10] Revenue and Earnings Expectations - The anticipated revenue decline is attributed to a challenging macroeconomic environment affecting consumer sentiment and discretionary spending [3] - The Outdoor & Recreation segment is expected to see a significant sales decrease of 9.9% in Q3 [4] Operational Factors - Management has forecasted a decline in net and core sales by 4-2%, with a normalized operating margin of 9.1-9.5% [4] - Cost-cutting measures and a streamlined organizational structure are expected to support profitability [5] Market Dynamics - Inflationary pressures, adverse currency fluctuations, and soft demand in the Outdoor & Recreation segment are ongoing challenges [3][10] - Newell Brands has reduced its reliance on Chinese imports, now sourcing only 15% of finished goods from China, down from 35% [7] Valuation and Stock Performance - Newell Brands is trading at a forward price-to-earnings ratio of 7.41X, which is below historical and industry averages, indicating an attractive investment opportunity [11] - The stock has declined 14.5% over the past three months, compared to a 5.1% decline in the industry [12]

Core Insights - Rivian Automotive, Inc. (RIVN) is expected to report its third-quarter 2025 results on November 4, with a consensus estimate of a loss per share of 72 cents and revenues of $1.46 billion, indicating a year-over-year revenue growth of 66.6% [1][2][8] Financial Performance - The consensus estimate for Rivian's loss has narrowed by a penny in the past 30 days, suggesting improved expectations [1] - In Q2 2025, Rivian reported an adjusted loss per share of 80 cents, which was wider than the consensus estimate of 65 cents but narrower than the loss of $1.21 from the previous year [2] - Rivian's net sales in Q2 2025 reached $1.3 billion, exceeding the consensus estimate of $1.26 billion, and reflecting a 12.5% increase year-over-year [2] Vehicle Deliveries and Revenue Growth - In Q3 2025, Rivian delivered 13,201 vehicles, an increase from 10,018 units in the same quarter of 2024 [3] - The company's software and services revenues surged by 347% year-over-year to $376 million in Q2 2025, largely due to a joint venture with Volkswagen AG, which is expected to contribute to revenue growth in the coming years [3][4] Operating Expenses and Margins - Total operating expenses in Q2 2025 decreased to $908 million from $924 million in the same period last year, primarily due to reduced research and development expenses, a trend likely to continue in Q3 [4] Earnings Expectations - Rivian has a positive Earnings ESP of +10.44%, indicating a higher Most Accurate Estimate compared to the consensus, which increases the likelihood of an earnings beat [5][6] - The company currently holds a Zacks Rank of 3, suggesting a hold position [6]

Core Insights - Corning Incorporated is a leading innovator in materials science, focusing on glass, ceramics, and optical physics, with operations in display technologies, optical communications, and specialty materials [1] - The company faces competition from firms like 3M and AGC Inc. in the materials and technology sectors [1] Price Target Trends - Corning's consensus price target has increased significantly over the past year, from $67.27 a year ago to $82.50 last month, indicating growing analyst optimism [2][4] - Three months ago, the average price target was $77.13, reflecting a steady increase in analysts' expectations regarding Corning's performance [3] - The upward trend in the price target suggests that analysts are increasingly confident in Corning's business segments and market position [3][4] Earnings Expectations - Analysts expect significant growth in Corning's Optical and Specialty Materials segments, which is driving positive sentiment [2][6] - Corning has a strong track record of exceeding earnings expectations, suggesting potential for an earnings beat in its upcoming report [4][6] - The overall upward trend in the consensus price target indicates confidence in Corning's ability to leverage its diverse business operations and market opportunities [5][6]

Core Insights - Revvity Inc. shares declined over 2% despite exceeding third-quarter adjusted earnings expectations and raising the full-year profit outlook [1] Financial Performance - The company reported adjusted earnings of $1.18 per share, surpassing the analyst consensus of $1.14 [2] - Revenue for the quarter was $699 million, aligning closely with expectations of $699.39 million, and reflecting a 2% increase from the prior-year quarter [2] - Organic revenue growth was reported at 1% year-over-year [2] Segment Performance - The Diagnostics division experienced a 3% rise in revenue, totaling $356 million [3] - The Life Sciences segment saw a 1% increase in revenue, reaching $343 million [3] - Both segments reported year-over-year declines in adjusted operating margins [3] Future Outlook - Revvity updated its 2025 revenue forecast to a range of $2.83 billion to $2.88 billion, accounting for foreign exchange adjustments [4] - The company maintained its organic growth outlook of 2–4% [4] - Adjusted earnings guidance was raised to $4.90–$5.00 per share, exceeding the consensus estimate of $4.87 [4]

Core Insights - Intercontinental Exchange Inc. (ICE) is anticipated to show improvements in both revenue and earnings for Q3 2025, with revenues expected to reach $2.4 billion, reflecting a 2.7% year-over-year growth [1][11] - The earnings per share (EPS) consensus estimate is $1.62, indicating a 4.5% increase from the previous year, although the estimate has decreased by 5.8% in the last 30 days [2][11] Revenue Expectations - The Zacks Consensus Estimate for Fixed Income and Data Services revenues is $612 million, while a more optimistic estimate is $616.9 million [6] - The Exchange segment is projected to generate $1.9 billion, with a more favorable estimate of $2 billion due to increased trading volumes in various markets [7] - The Mortgage Technology segment's revenues are estimated at $528 million, with a more conservative estimate of $491.2 million [8] Expense Projections - Total expenses are expected to rise by 2.2% to approximately $981.3 million, driven by higher compensation, professional expenses, and technology costs [9] - GAAP operating expenses are projected to be between $1.45 billion and $1.55 billion, while adjusted operating expenses are expected to range from $999 million to $1.005 billion [10] Market Activity - Continued share buybacks are likely to contribute positively to ICE's performance, with a reported 0.2% increase in average daily volume (ADV) for Q3 [12] - Total Commodities ADV decreased by 2.2% year-over-year, while Energy ADV saw a decline of 1.6%, contrasting with a 3.6% increase in Total Financials ADV [12]

Core Insights - Centene Corporation (CNC) is expected to report a loss of $0.21 per share for Q3 2025, with revenues projected at $47.62 billion, reflecting a year-over-year revenue growth of 13.3% despite a significant earnings decline of 113% [1][2][6]. Financial Performance - The earnings estimate for Q3 2025 has remained stable over the past 60 days, indicating a year-over-year plunge in earnings, while revenue projections suggest growth [2][3]. - For the full year 2025, Centene's revenue is estimated at $190.45 billion, representing a 16.8% increase year-over-year, but the EPS is projected to decrease by 76.4% [3][4]. Membership and Revenue Trends - Total commercial memberships are expected to increase by 26.6% year-over-year, with Medicare PDP memberships also showing nearly 17% growth [6][7]. - However, total membership is projected to decline by 2.2% year-over-year, primarily due to decreases in Medicaid and Medicare memberships [8]. - The consensus estimate for service revenues indicates a 7.2% decline from the previous year, while investment and other income is expected to fall by 11.7% [9]. Cost and Expense Outlook - Centene's medical costs are anticipated to remain high, with the health benefits ratio expected to rise to 93%, indicating a reduced portion of premiums available after claims [10]. - Total operating expenses are projected to increase by more than 15% in Q3, which may negatively impact the bottom line [10].

Core Insights - FTI Consulting, Inc. (FCN) reported strong third-quarter 2025 results, with both earnings and revenues exceeding the Zacks Consensus Estimate [1][11] - Following the positive results and raised guidance for 2025 earnings, FCN's stock increased by 2.7% since the earnings release on October 23 [1] - FCN expects full-year EPS to be between $8.20 and $8.70, surpassing the Zacks Consensus Estimate of $7.96 [1][10] Financial Performance - Quarterly adjusted EPS was $2.60, beating the Zacks Consensus Estimate by 34.7% and increasing 40.5% year over year [2][9] - Total revenues reached $956.2 million, exceeding the consensus estimate by 1.4% but declining 3.3% year over year [2][9] Segment Performance - Technology revenues decreased by 14.8% year over year to $94.08 million, primarily due to lower demand for M&A-related services [3] - Economic Consulting revenues fell 22% year over year to $173.09 million, driven by reduced demand for M&A-related antitrust services [3] - Corporate Finance & Restructuring revenues increased by 18.6% year over year to $379.2 million, attributed to higher demand for restructuring services [4] - Strategic Communications revenues rose by 20.8% year over year to $405 million, driven by increased demand for corporate reputation services [4] - Forensic and Litigation Consulting revenues grew by 15.4% year over year to $195 million, supported by higher realized bill rates for risk and investigations services [5] Margin and Cash Flow - Adjusted EBITDA was $130.6 million, up 26.8% year over year, with an adjusted EBITDA margin of 13.7%, an increase of 260 basis points [6][9] - FCN ended the quarter with cash and cash equivalents of $145.97 million, down from $152.8 million in the previous quarter, and generated $201.9 million from operating activities [7] Guidance - FCN now estimates full-year 2025 revenues to be between $3.685 billion and $3.735 billion, aligning with the Zacks Consensus Estimate of $3.71 billion [8]

Core Insights - Cboe Global Markets, Inc. (CBOE) is anticipated to show improvements in both revenue and earnings for the third quarter of 2025, with results expected to be reported on October 31 [1][2] Revenue Expectations - The Zacks Consensus Estimate for CBOE's third-quarter revenues is $579.03 million, reflecting an 8.8% increase from the previous year [1] - Market data revenues are estimated at $79.5 million, while access and capacity fees are projected to be $100.1 million [8] Earnings Projections - The consensus estimate for earnings is $2.46 per share, indicating a year-over-year increase of 10.8% [2] - The Earnings ESP for CBOE stands at +3.11%, with the Most Accurate Estimate at $2.53 per share [4] Factors Influencing Performance - Growth in index options, higher transaction and clearing fees, and increased market data and regulatory fees are expected to positively impact CBOE's performance [5][10] - Strong new subscriptions and unit sales in Cboe Data Vantage, along with pricing changes and brand investments, are likely to contribute to revenue growth [7] Market Dynamics - Increased trading volumes in Cboe options, U.S. equities, and European equities are anticipated to drive higher revenues in cash and spot markets [6] - The derivatives business is expected to benefit from rising transaction and clearing fees, alongside a growth in index options ADV [11][12] Additional Insights - Continued share buybacks are projected to support the bottom line for CBOE in the upcoming quarter [12]

Core Insights - The Hershey Company (HSY) is expected to report a revenue increase of 4.3% year-over-year, with third-quarter 2025 revenues estimated at $3.12 billion [1] - The consensus estimate for earnings has risen to $1.08, although this reflects a significant decrease of 53.9% compared to the previous year's figure [2] - Hershey's transformation initiatives and integrated operating model are anticipated to support solid sales growth, aided by supply chain improvements and enhanced marketing efforts [3] Revenue Growth Factors - Recent pricing actions, particularly across the U.S. confection portfolio, are expected to contribute to top-line expansion, alongside the Advancing Agility & Automation (AAA) program which is unlocking cost efficiencies [4] - Strong brand equity and innovation are sustaining volume momentum across retail channels, likely benefiting HSY's revenue in the third quarter [4] Profitability Concerns - Hershey's profitability is under pressure due to record-high cocoa prices, tariffs, and increased brand investments, which are expected to negatively impact margins [5] - The adjusted gross margin is projected to contract by 60 basis points to 35.3% for the third quarter [5] Earnings Predictions - The model predicts an earnings beat for Hershey, supported by a positive Earnings ESP of +0.19% and a Zacks Rank of 3 (Hold) [6] - Other companies with favorable earnings combinations include Vital Farms and Corteva, which are also expected to report growth in both top and bottom lines [7][9]